A single infusion of Celularity‘s PNK-007 — an investigational cell therapy derived from placental stem cells — is safe…
Articles by Alejandra Viviescas, PhD.
Nektar Therapeutics is launching a first-in-human Phase 1 clinical trial to assess the safety and efficacy…
Health Canada has approved Darzalex (daratumumab), in combination with standard Revlimid (lenalidomide) and dexamethasone, for people newly diagnosed…
A combination of Darzalex (daratumumab), Kyprolis (carfilzomib), and dexamethasone increases the time to disease progression or death…
GBR 1342, an investigational bispecific antibody developed by Glenmark Pharmaceuticals, was granted orphan drug designation by the U.S Food…
Evomela, an injectable formulation of melphalan, is now available in China as a high-dose conditioning therapy for people with…
Sleep apnea can drive the development of aggressive multiple myeloma in mice resistant to the cancer, a study found, suggesting…
Treatment with Kyprolis (carfilzomib) once a week is as safe and effective as the twice-weekly regimen used for the initial treatment…